St3Gal-IV Activators encompass a spectrum of chemical compounds that intricately facilitate the enhancement of St3Gal-IV, a sialyltransferase that catalyzes the addition of sialic acid to glycoproteins and glycolipids. CMP-Neu5Ac, the enzyme's direct donor substrate, and Uridine, which augments the synthesis of CMP-Neu5Ac, serve as pivotal activators by bolstering the substrate availability for St3Gal-IV catalysis. MnCl2 contributes essential Mn²⁺ cofactors, thus directly amplifying the enzyme's catalytic efficiency. Ambroxol and Retinoic acid provoke an upsurge in St3Gal-IV levels by modulating gene expression, thereby heightening the enzyme's sialylation capacity. PUGNAc and Benzyl-α-GalNAc strategically inhibit competing glycosylation pathways, indirectly fostering a conducive environment for St3Gal-IV's action, while Tunicamycin's inhibition of N-linked glycosylation potentially shifts the cellular equilibrium towards enhanced sialylation activity of St3Gal-IV. Betaine's role in protein stabilization ensures the proper conformation of St3Gal-IV, which is crucial for its optimal function.
The chemical landscape influencing St3Gal-IV is further enriched by compounds that modulate the cellular milieu and glycosylation precursors. Epigallocatechin gallate (EGCG) delicately adjusts cellular pathways that intersect with glycosyltransferase regulation, potentially facilitating an increase in St3Gal-IV's sialylation throughput. The availability of Galactose as a foundational glycosylation substrate ensures a plentiful starting point for St3Gal-IV's enzymatic action, thereby indirectly promoting its activity. In tandem, 5-Azacytidine's incorporation into nucleic acids may lead to an enhanced expression of St3Gal-IV, providing a boost to the enzyme's presence and activity within the cell. Collectively, these activators form a concerted network that not only ensures the enrichment of St3Gal-IV's substrate pool but also creates an intracellular context that is primed for the maximal operation of this pivotal glycosyltransferase, consequently enhancing the sialylation signature of cellular glycoconjugates without necessitating direct activation or upregulation of the enzyme's expression.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese(II) chloride provides Mn²⁺ ions, which are essential cofactors for sialyltransferases like St3Gal-IV. The presence of Mn²⁺ enhances the enzyme's catalytic activity, leading to increased sialylation of target molecules. | ||||||
Betaine | 107-43-7 | sc-214595 sc-214595A sc-214595B sc-214595C sc-214595D sc-214595E | 50 g 100 g 250 g 1 kg 2.5 kg 5 kg | $31.00 $41.00 $56.00 $163.00 $337.00 $592.00 | 2 | |
Betaine is an osmolyte that can stabilize the folding of proteins, including enzymes like St3Gal-IV. Proper folding may enhance the functional activity of the sialyltransferase, leading to increased enzyme activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to modulate various cellular pathways, including those involving glycosylation. It can indirectly enhance St3Gal-IV activity by affecting pathways that regulate glycosyltransferases, possibly enhancing the sialylation process. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can influence gene expression and has been shown to upregulate the expression of certain glycosyltransferases. It may enhance St3Gal-IV activity by increasing enzyme levels within the cell. | ||||||
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
Galactose is a substrate for initial glycosylation reactions. By supplementing with galactose, the pool of glycoprotein and glycolipid substrates available for further modification by St3Gal-IV is increased, potentially enhancing its activity. | ||||||
Uridine | 58-96-8 | sc-296685 sc-296685A | 1 g 25 g | $61.00 $100.00 | 1 | |
Uridine supplementation can enhance the synthesis of the sugar nucleotide CMP-Neu5Ac, the donor substrate for St3Gal-IV. Increased availability of this substrate can enhance the enzyme's sialylation activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a cytidine analog that can incorporate into RNA and DNA and affect gene expression. It may upregulate the expression of St3Gal-IV, enhancing its activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation. By inhibiting this competitive pathway, tunicamycin could potentially shift the glycosylation balance toward increased sialylation by St3Gal-IV. | ||||||